# Determination of the Antidepressant Duloxetine in Plasma to Improve the Knowledge of the Analgesic Action of Antidepressants on Chronic Neuropathic Pain

> **NCT02846701** · PHASE4 · COMPLETED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 8 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** duloxetine

## Key facts

- **NCT ID:** NCT02846701
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-17
- **Primary completion:** 2017-06-20
- **Final completion:** 2019-06-16
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02846701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02846701, "Determination of the Antidepressant Duloxetine in Plasma to Improve the Knowledge of the Analgesic Action of Antidepressants on Chronic Neuropathic Pain". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02846701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*